Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

Abstract

According to the Barcelona Clinic Liver Cancer (BCLC) staging system, surgical resection is recommended only for BCLC-0 and BCLC-A hepatocellular carcinoma (HCC). Nevertheless, several investigators have recently advocated for widening the resection criteria for HCC to select patients with BCLC-B and less frequently BCLC-C tumors. The available studies have reported a 5-year survival rate ranging from 25% to 63% following resection of select patients with multinodular HCC. The role of liver resection for macrovascular invasive HCC still remains unclear. The present review aimed to summarize the available evidence regarding the outcomes of patients who underwent resection for BCLC-B/C HCC as well as highlight the proposed criteria for resection beyond the current BCLC guidelines.

Keywords

Resection / HCC / BCLC / surgery / criteria

References

[1] Lafaro KJ,Pawlik TM.Epidemiology of hepatocellular carcinoma.Surg Oncol Clin N Am2015;24:1-17

[2] Rahib L,Matrisian LM.Estimated projection of US cancer incidence and death to 2040.JAMA Netw Open2021;4:e214708 PMCID:PMC8027914

[3] Marrero JA,Barrat A.Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.Hepatology2005;41:707-16

[4] O'Neil BH.Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.Oncologist2007;12:1425-32

[5] Cillo U,Grigoletto F.Prospective validation of the Barcelona Clinic Liver Cancer staging system.J Hepatol2006;44:723-31

[6] Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma.J Hepatol2018;69:182-236

[7] Marrero JA,Sirlin CB.Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.Hepatology2018;68:723-50

[8] Wada H,Noda T.Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.Surgery2016;160:1227-35

[9] Bhandare MS,Shetty N.Liver resection for HCC outside the BCLC criteria.Langenbecks Arch Surg2018;403:37-44

[10] Hyun MH,Kim JH.Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a meta-analysis of high-quality studies.Hepatology2018;68:977-93

[11] Lim C,Osseis M.Short-term outcomes following hepatectomy for hepatocellular carcinoma within and beyond the BCLC guidelines: a prospective study.HPB (Oxford)2018;20:222-30

[12] Tsilimigras DI,Moris D.Assessing textbook outcomes following liver surgery for primary liver cancer over a 12-year time period at major hepatobiliary centers.Ann Surg Oncol2020;27:3318-27

[13] She WH.Strategies to increase the resectability of hepatocellular carcinoma.World J Hepatol2015;7:2147-54 PMCID:PMC4550869

[14] Guo H,Lu Q.Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages.Cancer Manag Res2018;10:361-9 PMCID:PMC5827460

[15] Torzilli G,Kokudo N.A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?.Ann Surg2013;257:929-37

[16] Hsu CY,Huang YH.Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.Ann Surg Oncol2012;19:842-9

[17] Tada T,Toyoda H.Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: a multicenter study from Japan.Cancer Sci2017;108:1414-20 PMCID:PMC5497930

[18] Zhong JH,Gong WF.Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.Ann Surg2014;260:329-40

[19] Labgaa I,Melloul E.Surgical resection versus transarterial chemoembolization for intermediate stage hepatocellular carcinoma (BCLC-B): an unsolved question.Hepatology2019;69:923

[20] Mo DC,Zhong JH.Letter to the Editor: hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a comment for moving forward.Hepatology2019;70:446-7

[21] Gui CH,D'Cruz RT.Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.Eur J Surg Oncol.46(5):763-771

[22] Moris D.Ignore reality but not the consequences of its ignorance: Broaden guidelines in surgery of hepatocellular carcinoma.Hepatology2017;65:1772-3

[23] Ho MC,Tsang YM.Liver resection improves the survival of patients with multiple hepatocellular carcinomas.Ann Surg Oncol2009;16:848-55

[24] Kim H,Hong SK.Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.Br J Surg2017;104:1045-52

[25] Tsilimigras DI,Sahara K.Prognosis after resection of barcelona clinic liver cancer (BCLC) Stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification.Ann Surg Oncol2019;26:3693-700

[26] Yin L,Li AJ.Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT.J Hepatol2014;61:82-8

[27] Li ZL,Guo JW.Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: a multicenter analysis of 1,066 patients.Eur J Surg Oncol2019;45:800-7

[28] Tsilimigras DI,Moris D.Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: a multi-institutional analysis of 1,010 patients.Surgery2019;166:967-74

[29] Kanda M,Yoshida H.Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.Liver Int2008;28:1256-63

[30] Pawlik TM,Abdalla EK.Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study.Surgery2005;137:403-10

[31] Chok KS,Chan SC,Fan ST.Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis.World J Surg2014;38:490-6

[32] Worns MA,Niederle IM.The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib.Dig Liver Dis2013;45:408-13

[33] Ruzzenente A,Pachera S.Is liver resection justified in advanced hepatocellular carcinoma?.J Gastrointest Surg2009;13:1313-20

[34] Costentin CE,Laurent A.Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: a propensity score analysis.Liver Int2017;37:1869-76

[35] Couri T.Goals and targets for personalized therapy for HCC.Hepatol Int2019;13:125-37

[36] Inoue Y,Ishizawa T.Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?.Surgery2009;145:9-19

[37] Wang Y,Ge RL,Wei G.Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study.Ann Surg Oncol2013;20:914-22

[38] Le Treut YP,Ananian P.Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series.J Gastrointest Surg2006;10:855-62

[39] Tsilimigras DI,Hyer JM.Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.Br J Surg2020;107:854-64

[40] Kudo M,Ueshima K,Kitano M.Subclassification of BCLC B stage hepatocellular carcinoma and treatment strategies: proposal of Modified Bolondi's Subclassification (Kinki Criteria).Dig Dis2015;33:751-8

[41] Arizumi T,Iwanishi M.Validation of Kinki Criteria, a modified substaging system, in patients with intermediate stage hepatocellular carcinoma.Dig Dis2016;34:671-8

[42] Tsilimigras DI,Moris D.Utilizing machine learning for pre- and postoperative assessment of patients undergoing resection for BCLC-0, A and B hepatocellular carcinoma: implications for resection beyond the BCLC guidelines.Ann Surg Oncol2020;27:866-74

[43] Tsilimigras DI,Paredes AZ.Overall tumor burden dictates outcomes for patients undergoing resection of multinodular hepatocellular carcinoma beyond the Milan criteria.Ann Surg2020;272:574-81